We came across a bullish thesis on Sana Biotechnology, Inc. (SANA) on wallstreetbets Subreddit Page by Intrepid_Web5454. In ...

The pancreatic cell therapy is engineered with Sana’s (NASDAQ:SANA) hypoimmune, or HIP, technology. Sana (SANA) said results showed the survival and function of pancreatic beta cells at four ...

We recently compiled a list of the 10 Hottest Smid-Cap Stocks So Far In 2025. In this article, we are going to take a look at ...

Analyst Vikram Purohit from Morgan Stanley maintained a Buy rating on Sana Biotechnology (SANA – Research Report) and keeping the price target ...

Shares of Sana Biotechnology surged after the company ... an allogeneic primary islet cell therapy engineered with its hypoimmune technology, into a patient with type 1 diabetes without the ...

(MENAFN- GlobeNewsWire - Nasdaq) First-in-Human Study Provides Evidence that Sana's Hypoimmune (HIP) technology Enables Transplanted Islet Cells to Avoid Immune Rejection and Produce Insulin Without ...

Sana Biotechnology, Inc. engages in the research ... executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen ...